| Product Name | MF | CAS | Details |
|---|
| 1-Propyl-1H-pyrazole-4-carbaldehyde | C7H10N2O | 473249-36-4 | Details |
| H-YPEAPPSVR^-OH | Details |
| 1-(2-Methoxyethyl)-3,5-dimethyl-1H-pyrazole | C8H14N2O | 1341388-28-0 | Details |
| 7-Bromo-1H,2H,3H,3aH,4H,5H-pyrrolo[1,2-a]quinoxalin-4-one | C11H11BrN2O | 1501832-57-0 | Details |
| 9H-Fluoren-9-ylmethyl N-[(2S)-4-methyl-1-oxopentan-2-yl]carbamate | C21H23NO3 | 146803-42-1 | Details |
| 7-Deazaguanine | C6H6N4O | 7355-55-7 | Details |
| USP14 antibody | Details |
| Ethyl 2,2-difluoro-2-(4-hydroxypiperidin-4-yl)acetate hydrochloride | 1258639-20-1 | Details |
| SFRS8 Blocking Peptide | Details |
| Ethyl 3-(1-adamantyl)-3-oxopropanoate | C15H22O3 | 19386-06-2 | Details |
| Homomangiferin | C20H20O11 | 21794-66-1 | Details |
| 8-Fluoro-2-oxo-1,2,3,4-tetrahydroquinoline-6-carboxylic acid | C10H8FNO3 | 1225878-25-0 | Details |
| ELOVL7 antibody | Details |
| Lys-Thymic Factor trifluoroacetate salt | C41H69F3N14O19 | 318950-01-5 | Details |
| IV-23 | C18H18BrNO4 | 2326007-49-0 | Details |
| Glutaraldehyde - 50 wt. % aqueous solution | C5H8O2 | 111-30-8 | Details |
| Dopamine Receptor 2 Blocking Peptide (Rat) | Details |
| ACAA1 protein (His tag) | Details |
| Cytokeratin 222 Pseudogene antibody | Details |
| 2-Methyl-2H-[1,2,3]triazol-4-ylamine | C3H6N4 | 936940-63-5 | Details |
| 2-[(3-Methylphenyl)methoxy]propanoic acid | C11H14O3 | 1603174-94-2 | Details |
| Vitalethine | C12H22N4O6S2 | 143129-01-5 | Details |
| TK1 protein (His tag) | Details |
| H-IILEALR^-OH | Details |
| (3-((hydroxyimino)ethyl)-4-methyl(2,5-thiazolyl))phenylamine | C12H13N3OS | 88324-03-2 | Details |
| Mca-(Asn670,Leu671)-Amyloid beta/A4 Protein Precursor770 (667-675)-Lys(Dnp) amide ammonium salt | C68H89N15O26 | 1802078-32-5 | Details |
| 5HT6 antibody | Details |
| DUSP3 antibody | Details |
| 4-Methoxy-2-methylpyrrolidine-2-carboxylic acid hydrochloride | C7H14ClNO3 | 2031259-19-3 | Details |
| PCDHB16 Blocking Peptide | Details |
| N-alpha-tert-BOC-N-epsilon-formyl-L-lysine | C12H22N2O5 | 2483-47-8 | Details |
| 1-(Boc-amino)-3,6-dioxa-8-octaneazide | C11H22N4O4 | 950683-55-3 | Details |
| 2-{[2-(Diethylamino)ethyl]sulfanyl}acetic acid hydrochloride | C8H18ClNO2S | 1171451-28-7 | Details |
| (1S)-1-(2,5-Dimethoxyphenyl)ethan-1-ol | C10H14O3 | 156713-10-9 | Details |
| Kaempferol 3-2-Sophoroside | C27H30O16 | 19895-95-5 | Details |
| HIST1H1T Blocking Peptide | Details |
| 4-Methylumbelliferyl oleate | C28H40O4 | 18323-58-5 | Details |
| De-4'-o-methylyangambin | C23H28O8 | 149250-48-6 | Details |
| 4-Chloro-7-methoxypyrido[3,2-d]pyrimidine | C8H6ClN3O | 1256811-43-4 | Details |
| AWZ1066S | C19H19F3N6O | 2239272-16-1 | Details |
| N'-Hydroxypiperidine-2-carboximidamide | C6H13N3O | 1461726-91-9 | Details |
| 4,5-Dichloro-2-methoxypyrimidine | C5H4Cl2N2O | 1240601-33-5 | Details |
| Octyldecyl 2-acetamido-2-deoxy-b-D-glucopyranoside | C26H51NO6 | 173725-29-6 | Details |
| 14-3-3 zeta theta antibody (Thr232) | Details |
| 4-Amino-3-(pyridin-4-yl)butan-1-ol dihydrochloride | 2361643-80-1 | Details |
| 1-Boc-4-(2-iodoethyl)piperidine | C12H22INO2 | 89151-46-2 | Details |
| 2-Methyl-1-oxo-1,2-dihydroisoquinoline-3-carboxylic acid | C11H9NO3 | 89806-32-6 | Details |
| 6-Amino-6-deoxy-a-cyclodextrin hydrochloride | C36H66N6O24 | 30899-95-7 | Details |
| NUP155 antibody | Details |
| 2-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)bicyclo[3.1.0]hexane-2-carboxylic acid | C22H21NO4 | 1865612-30-1 | Details |
| HRP-IgG Conjugation Kit | Details |
| 3-(1H-Indol-3-yl)acrylic acid | C11H9NO2 | 1204-06-4 | Details |
| GSK1016790A | C28H32Cl2N4O6S2 | 942206-85-1 | Details |
| 1-[(3-Methoxyphenyl)methyl]cyclopropan-1-amine hydrochloride | C11H16ClNO | 1439903-03-3 | Details |
| 3,3-Dibromoprop-2-en-1-ol | C3H4Br2O | 101084-79-1 | Details |
| AAAS antibody | Details |
| tert-Butyl (2R)-2-(2-chloroacetamido)-4-methylpentanoate | C12H22ClNO3 | 1909288-17-0 | Details |
| ALK1 antibody | Details |
| Citric acid anhydrous | C6H8O7 | 77-92-9 | Details |
| rac-(1R,2S)-2-(Pyridin-3-yl)cyclohexan-1-ol | C11H15NO | 1450597-02-0 | Details |
| ApoA-II protein | Details |
| 4-Nitro-5-trifluoromethyl-1H-pyrazole | C4H2F3N3O2 | 1046462-99-0 | Details |
| 2-(Aminooxy)-2-methylpropan-1-ol hydrochloride | C4H12ClNO2 | 372105-52-7 | Details |
| 4-(4-Methylphenyl)-5-sulfanyl-8-thia-4,6-diazatricyclo[7.4.0.0,2,7]trideca-1(9),2(7),5-trien-3-one | C17H16N2OS2 | 59898-69-0 | Details |
| Osteoblast Activating Peptide (human) trifluoroacetate salt | Details |
| N-Methyl-2-phenylacetamide | C9H11NO | 6830-82-6 | Details |
| VPS8 antibody | Details |
| 2,3,4-Trifluoro-5-sulfamoylbenzoic acid | C7H4F3NO4S | 2090303-92-5 | Details |
| 7-(Propan-2-yl)-[1,2,4]triazolo[1,5-a]pyrimidine-5-carboxylic acid | C9H10N4O2 | 878453-66-8 | Details |
| 2-(2,3-Dihydro-1-benzofuran-7-yl)-2-hydroxyacetic acid | C10H10O4 | 1594835-92-3 | Details |
| 1-Hydroxycycloheptanecarboxylic acid | C8H14O3 | 20920-03-0 | Details |
| 2-{4-[3-(Trifluoromethyl)benzenesulfonamido]phenyl}acetic acid | C15H12F3NO4S | 735305-35-8 | Details |
| 1-Bromohex-5-en-2-one | C6H9BrO | 145967-22-2 | Details |
| LHRH hydrochloride salt | C55H76ClN17O13 | 51952-41-1 | Details |
| 2’-O,4’-C-Methylenecytidine | C10H13N3O5 | 206055-69-8 | Details |
| 2-Hydroxybenzylamine hydrate | C7H11NO2 | 1134974-97-2 | Details |
| Peripheral Myelin Protein P0 (180-199) | Details |
| PLK4 antibody | Details |
| 1-[4-(Furan-2-yl)-5-methyl-1,3-thiazol-2-yl]ethan-1-amine hydrochloride | C10H12N2OS.ClH | 1909309-26-7 | Details |
| 4-[2-(4-Bromophenoxy)ethoxy]-3-ethoxybenzaldehyde | C17H17BrO4 | 568557-49-3 | Details |
| Rel-[(1S,3S)-3-phenylcyclobutyl]methanamine | C11H15N | 1232062-11-1 | Details |
| Rabbit anti Goat IgG (H + L) (Agarose Conjugated) | Details |
| 5-Hydroxy-2,3-dihydro-1λ?,2-benzothiazole-1,1-dione | 43059-32-1 | Details |
| 6-Azaspiro[3.5]nonan-9-one hydrochloride | C8H14ClNO | 2179070-00-7 | Details |
| 1,2,3,4-Tetra-O-benzoyl-6-O-tert-butyldiphenylsilyl-a-D-mannopyranose | C50H54O6Si | 1222709-77-4 | Details |
| SPRYD3 Blocking Peptide | Details |
| ZBTB2 antibody | Details |
| PERLD1 Blocking Peptide | Details |
| 2-(Benzoylamino)-2-phenylacetic acid | C15H13NO3 | 29670-63-1 | Details |
| 2-[3-(Methoxycarbonyl)-5-methyl-1H-pyrazol-1-yl]acetic acid | C8H10N2O4 | 1211513-40-4 | Details |
| 2-[3-Methyl-6-phenyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-1-yl]acetic acid | C16H12F3N3O2 | 937605-80-6 | Details |
| 4-Nitrophenyl 2-acetamido-3-azido-2,3-dideoxy-b-D-galactopyranoside | C14H17N5O7 | Details |
| 1-Ethyl-N-(2-methylpropyl)-1H-pyrazol-4-amine dihydrochloride | C9H18ClN3 | 1909326-24-4 | Details |
| Methyl 3-oxo-2-(propan-2-yl)pentanoate | C9H16O3 | 1248205-88-0 | Details |
| ALKBH3 protein (His tag) | Details |
| 1-(Trifluoromethyl)cyclopropane-1-carbonitrile | C5H4F3N | 96110-56-4 | Details |
| 3-(6-Methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)propanoic acid | C8H10N2O4 | 28181-39-7 | Details |
| Methyl 2-amino-1,3-benzoxazole-7-carboxylate | C9H8N2O3 | 910123-45-4 | Details |
| UK 432097 | C40H47N11O6 | 380221-63-6 | Details |
| Anthranilyl-HIV Protease Substrate V trifluoroacetate salt | C50H76N14O13 | 210644-48-7 | Details |
| Product Total： Product Page： | ||||
| 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 | ||||